<?xml version="1.0" encoding="UTF-8"?>
<p>Fresh blood (5 mL) was collected in an EDTA tube and centrifuged at 1000× 
 <italic>g</italic> for 5 min at 4 °C. The supernatant was removed, and the pellet with red blood cells was washed five times with saline solution (0.9% sterile) and then suspended in the same solution to obtain a 1% (
 <italic>v/v</italic>) red cell solution. The test compound was diluted in a 1% DMSO solution and tested in triplicate at concentrations of 1000 to 15.6 μg/mL in seven serial dilutions (1:2), and 100 μL of the 1% red blood cell suspension was added (
 <italic>v/v</italic>) in each well. The resulting suspensions were incubated for 60 min at 37 °C. After incubation, the samples were centrifuged for 2 min at 1000× 
 <italic>g</italic>. The supernatants were transferred to 96-well plates and the release of hemoglobin was measured by absorbance at 450 nm (Abs450nm) using a BioTek Synergy HT multiplate reader. To control 100% hemolysis, red blood cells were suspended in 1% (
 <italic>v/v</italic>) Triton X-100. As a control without hemolysis, a 0.9% saline solution was used. The percentage of hemolysis was determined using the following equation: [(Abs450nm treated sample-Abs450nm untreated)/(Abs450nm1% Triton X-100-Abs450nm untreated)] × 100 [
 <xref rid="B22-pathogens-09-00889" ref-type="bibr">22</xref>].
</p>
